Choose leads from a large design series
Compare many linker, warhead, attachment-point, or E3-ligase variants and identify the smallest set that preserves meaningful structural and chemical diversity.
When your degrader pipeline holds dozens of candidates, the cost of advancing the wrong one is high. We score every candidate across structure, potency, selectivity, ADMET, and synthesis so your team advances a defensible shortlist instead of a favorite.
Compare many linker, warhead, attachment-point, or E3-ligase variants and identify the smallest set that preserves meaningful structural and chemical diversity.
Determine why a compound with strong binding may show weak degradation, poor selectivity, limited permeability, or an unfavorable concentration-response profile.
Rank unsynthesized designs using modeled ternary geometry, property predictions, synthetic accessibility, and similarity to measured compounds in the same series.
Bring structural, biochemical, cellular, ADMET, selectivity, and chemistry evidence into one traceable package for cross-functional review.
Assess interface complementarity, productive protein orientation, linker strain, accessible ubiquitination geometry, and stability across alternative ternary-complex models. Molecular dynamics evidence can distinguish a plausible docked pose from an interaction network that remains stable over time.
Compare DC50, Dmax, degradation rate, duration, and concentration-response shape rather than relying on one potency value. Hook-effect behavior and assay context are considered so strong performance at one concentration does not dominate the full profile.
Integrate target-family binding, quantitative proteomics, known E3 neo-substrates, and cell-context evidence. Candidates with clean on-target degradation can be separated from compounds that achieve potency through broad or difficult-to-control proteome effects.
Evaluate permeability, solubility, efflux risk, metabolic stability, protein binding, and other exposure-related liabilities relevant to the intended route and tissue. Measured properties are interpreted together because improving one property can worsen another.
Review route length, difficult transformations, linker availability, purification burden, stereochemical complexity, cost, and scalability. This keeps highly ranked designs practical for follow-up chemistry instead of rewarding compounds that are unlikely to be made reproducibly.
Map chemical-space differentiation across warhead, linker, ligase recruiter, and attachment-point choices. Novelty is treated as a program-specific decision factor and can be raised, lowered, or excluded depending on the project objective.
Candidate rankings are bucketed into decision tiers so chemistry and biology can act on the grouping rather than argue over one decimal place of a composite score.
A prioritization project does not require every candidate to have a complete experimental package. We first separate measured evidence from calculated evidence, identify which gaps could change the ranking, and use modeling only where it adds decision value.
The workflow gathers heterogeneous evidence, normalizes it into comparable scores, and surfaces uncertainty instead of hiding it.
Request a Prioritization ScopeAlign on the goal—nomination, lead optimization, or mechanistic triage—and set criterion weights with your team.
Collect structures, degradation data, selectivity, ADMET, and synthesis inputs for every candidate in the pool.
Fill evidence gaps with modeling—ternary geometry, ADMET, and selectivity predictions—flagged explicitly as computed.
Normalize each criterion, apply weights, and bucket candidates into decision tiers with confidence notes.
Provide the ranked matrix, uncertainty flags, and a validation plan that resolves the top competing hypotheses.
A single number can conceal that two candidates are close on every criterion except synthesis cost. We expose per-criterion values, normalization rules, evidence sources, and weights so the ranking can be reviewed and adjusted by chemistry, biology, DMPK, and project leadership. The objective is a decision trail your team can challenge—not a black-box score it must accept.
Representative output groups candidates by decision value, so chemistry and biology see the advance, optimize, investigate, and deprioritize boundaries clearly. Candidates near a boundary are highlighted for review instead of being separated by an insignificant decimal difference.
A candidate supported by complete experimental data should not be treated as equivalent to one supported mainly by predictions. Confidence is therefore tracked separately from performance, allowing a promising but uncertain design to remain visible without silently outranking a better-supported lead.
Every score retains its evidence type, assay or model source, conditions, date, and confidence level. Calculated values can fill a decision gap, but they are not presented as if they were experimental observations.
Weight and threshold sensitivity analyses identify candidates that remain strong across reasonable assumptions. If small changes reverse the shortlist, the result is reported as decision-sensitive rather than definitive.
Strong ternary geometry, weak cellular degradation, and poor permeability may indicate different bottlenecks. We preserve these conflicts and use them to propose discriminating experiments instead of averaging them into an uninformative score.
The top tier can include more than the highest-scoring close analogs. Where appropriate, structurally distinct representatives are retained to reduce series risk and give the next experimental round more information.
Candidate-level values, normalized scores, criterion weights, composite results, data provenance, and sortable rankings for the full pool.
Advance, optimize, investigate, and deprioritize groups with explicit boundaries and a concise rationale for each top candidate.
Key ternary poses, interaction summaries, linker observations, property profiles, and major strengths or liabilities for priority compounds.
Measured-versus-predicted flags, missing-data map, rank stability across weighting scenarios, and candidates close to tier boundaries.
Recommended assays and experiments selected for their ability to resolve the most important competing candidate hypotheses.
A multidisciplinary results discussion plus presentation-ready figures and editable data tables for internal decision meetings.
The authors showed that ternary-complex affinity and cooperativity drive degradation potency and rate, and that excess affinity can suppress degradation via a hook effect. Candidate ranking therefore requires more than potency.
Quantitative proteomics across 91 degraders revealed that chemistry and ligase choice produce distinct global degradation profiles, making selectivity a measurable criterion rather than an assumption.
A strong prioritization project starts by defining the decision the ranking must support.
We score ternary-complex quality, degradation potency and hook-effect behavior, target selectivity, ADMET properties, and synthesis feasibility. Weights are tuned to your program goals and the decision at hand.
Weights are agreed with your team at scoping. A potency-driven program weights degradation more heavily, while a selectivity-sensitive program elevates proteomics and off-target considerations.
Yes. Missing data are handled with explicit model predictions and uncertainty flags rather than silently imputed. Ranks distinguish structurally supported candidates from those awaiting confirmatory data.
Yes. High ternary affinity can paradoxically suppress degradation at high concentration. We flag potential hook-effect risk and incorporate it into the prioritization rather than ranking on potency alone.
The framework can be adapted to a focused lead series or a larger virtual design set. The practical project size depends on the depth of structural modeling required, how much experimental evidence is available, and whether missing properties need to be predicted. We can also use a staged approach: rapidly triage the full pool, then apply deeper modeling to the most promising subset.
Yes. The candidate pool may include different E3 recruiters, warheads, linkers, and attachment points. We normalize comparable endpoints while retaining the relevant assay context and structural mechanism. Where cross-series measurements are not directly comparable, the limitation is shown explicitly and the ranking can be reported within series as well as across the full pool.
A ranked candidate matrix with per-criterion scores, weights, confidence notes, a tiered shortlist, and a recommended validation plan for the top candidates.
Share your candidate structures and any degradation, selectivity, or ADMET data. CD ComputaBio will scope a weighted prioritization and identify the experiments that would sharpen the ranking. Related services: AI PROTAC Ternary Complex Modeling, PROTAC Binding Stability Analysis by MD, PROTAC Bioavailability Prediction.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk